Primary Human Papillomavirus Screening for Cervical Cancer in the United States-US Food and Drug Administration Approval, Clinical Trials, and Where We Are Today

Authors

Authors

R. Nayar; R. A. Goulart; P. G. Tiscornia-Wasserman;D. D. Davey

Comments

Authors: contact us about adding a copy of your work at STARS@ucf.edu

Abbreviated Journal Title

Cancer Cytopathol.

Keywords

CONSENSUS GUIDELINES; CYTOLOGY; WOMEN; RISK; PREVENTION; VACCINATION; PREVALENCE; MANAGEMENT; TESTS; AGE; Oncology; Pathology

Abstract

The US Food and Drug Administration recently approved the additional indication of Primary Screening for the Roche cobas human papillomavirus test. This commentary includes an overview of the supporting clinical trial data, issues this approval will present for laboratorians, and proposed clinical management guidelines for abnormal screening results.

Journal Title

Cancer Cytopathology

Volume

122

Issue/Number

10

Publication Date

1-1-2014

Document Type

Editorial Material

DOI Link

http://dx.doi.org/10.1002/cncy.21480

Language

English

First Page

720

Last Page

729

WOS Identifier

WOS:000343877100004

ISSN

1934-662X

Recommended Citation

"Primary Human Papillomavirus Screening for Cervical Cancer in the United States-US Food and Drug Administration Approval, Clinical Trials, and Where We Are Today" (2014). Faculty Bibliography 2010s. 5879.
https://stars.library.ucf.edu/facultybib2010/5879